Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Wegovy is a brand name for semaglutide, a medication approved for chronic weight management in adults with obesity or overweight individuals with at least one weight-related comorbidity
He both treats patients and does research
Referral to registered dietitians, behavioral health specialists, or comprehensive weight management programs can provide additional support for sustained behavior change and weight maintenance, whether patients continue medication or attempt discontinuation with close monitoring
That weekly rate is our assumption, not a figure the published Phase 2 Retatrutide trial reported
The dosing schedule is standardized across most treatment protocols: Week 14 starts at 2.5 mg, Week 58 increases to 5 mg, and further increases occur in 2.5 mg increments every four weeks until therapeutic benefit is achieved or a target dose is reached
US$ 26.39
US$ 20.55
US$ 21.61
US$ 24.03
US$ 28.29
US$ 25.06
US$ 27.94
